XML 10 R4.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2022
Dec. 31, 2021
Revenue $ 1,192 $ 845 $ 2,161 $ 1,327
Cost of revenue 711 492 1,407 719
Gross profit 481 353 754 608
Operating expenses:        
Research and development 3,326 4,134 7,083 8,132
General and administrative 6,810 10,071 15,060 18,203
Performance of contract liability to affiliate (7) (70) (19) (131)
Total operating expenses 10,129 14,135 22,124 26,204
Loss from operations (9,648) (13,782) (21,370) (25,596)
Equity in net (losses) earnings of affiliate 0 37 (9) 37
Foreign currency (loss)/gain, net (108) (163) 699 2,140
Fair value adjustment to VericiDx investment (345) (1,414) (1,199) (2,021)
Fair value adjustment to convertible notes 440 0 (730) 0
Other income, net 97 0 211 12
Net loss before income taxes (10,444) (15,322) (22,398) (25,428)
Income tax expense 0 0 1 0
Net loss (10,444) (15,322) (22,397) (25,428)
Other comprehensive income (loss):        
Changes in the fair value of the convertible notes through other comprehensive income (920) 0 (523) 0
Foreign exchange translation adjustment 588 97 (499) (2,488)
Comprehensive loss $ (10,776) $ (15,225) $ (23,419) $ (27,916)
Earnings Per Share, Basic $ (0.14) $ (0.21) $ (0.30) $ (0.35)
Earnings Per Share, Diluted $ (0.14) $ (0.21) $ (0.30) $ (0.35)
Weighted Average Number of Shares Outstanding, Basic 74,891,844 72,285,941 74,848,278 72,258,372
Weighted Average Number of Shares Outstanding, Diluted 74,891,844 72,285,941 74,848,278 72,258,372